Investing.com - Surgery Partners Inc (NASDAQ: SGRY) reported first quarter EPS of $0.27, $0.07 better than the analyst estimate of $0.20. Revenue for the quarter came in at $707.1M versus the consensus estimate of $688.06M.
Guidance
Surgery Partners Inc sees Q1 2023 revenue of $2.75B versus the analyst consensus of $2.81B.
Surgery Partners Inc's stock price closed at $33.45. It is up 14.55% in the last 3 months and down -40.71% in the last 12 months.
Surgery Partners Inc saw 0 positive EPS revisions and 9 negative EPS revisions in the last 90 days. See Surgery Partners Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Surgery Partners Inc's Financial Health score is "good performance".
Check out Surgery Partners Inc's recent earnings performance, and Surgery Partners Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar